Japan National Cancer Center Starts Clinical Trials With Biliary Tract Drug
This article was originally published in PharmAsia News
Executive Summary
The National Cancer Research Center will start a clinical study regarding the development of a molecular target drug for biliary tract cancer, it was announced on June 6.